Ninox Ltd.

Ninox Ltd., established in 2023, is at the forefront of innovation in medical gas production, delivering on-demand solutions for healthcare and industry. The company specializes in producing medical-grade gases, including inhaled Nitric Oxide (iNO), directly from ambient air at the point of care. By overcoming the challenges of traditional gas supply systems—such as high costs, complex logistics, and limited availability—Ninox provides portable, efficient devices tailored for clinical, outpatient, and homecare use. The company’s flagship products include Nixhale™, a bedside device for tankless iNO delivery with real-time patient monitoring, and CanNO™, a portable system enabling on-site production and refilling of pharmaceutical-grade medical gases. With advanced technology, Ninox ensures high quality while reducing dependency on conventional supply chains. These versatile solutions integrate seamlessly into diverse environments, including hospitals, medical logistics centers, and transportation networks, offering streamlined and cost-effective alternatives.Ninox is driving the expansion of inhaled Nitric Oxide therapy beyond ICU settings into outpatient care, meeting the increasing global demand for accessible and affordable treatment options. Committed to safety, quality, and innovation, Ninox is redefining the future of medical gas logistics and delivery for healthcare providers worldwide.